Denis Ouzan Selected Research

Denis Ouzan Research Topics

Disease

15	Infections 01/2021 - 01/2002
14	Chronic Hepatitis C 01/2023 - 05/2002
14	Hepatitis C 01/2023 - 04/2003
11	Fibrosis (Cirrhosis) 01/2023 - 04/2004
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2007
4	Chronic Hepatitis (Chronic Active Hepatitis) 12/2013 - 08/2007
2	Chronic Hepatitis B 01/2020 - 10/2016
2	Substance-Related Disorders (Drug Abuse) 09/2010 - 04/2003
2	Virus Diseases (Viral Diseases) 06/2007 - 02/2006
1	Chronic Renal Insufficiency 01/2023
1	Hydrothorax 01/2022
1	Ascites 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Hemorrhage 01/2022
1	Hepatorenal Syndrome 01/2022
1	Portal Hypertension 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Disease Progression 01/2022
1	Hepatopulmonary Syndrome 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Coinfection 01/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Neutropenia 01/2018
1	Viremia 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Diabetes Mellitus 01/2018
1	Thrombocytopenia 4 01/2018
1	Leukopenia 01/2018
1	Chronic Disease (Chronic Diseases) 04/2011
1	Mental Disorders (Mental Disorder) 01/2010
1	Liver Diseases (Liver Disease) 08/2007
1	Overweight 08/2007
1	Autoimmune Hepatitis 04/2006
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2006
1	Alcoholism (Alcohol Abuse) 04/2003

Drug/Important Bio-Agent (IBA)

13	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 10/2003
10	InterferonsIBA 11/2018 - 04/2003
9	Antiviral Agents (Antivirals)IBA 01/2019 - 10/2003
7	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2004
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 06/2013
3	BilirubinIBA 01/2022 - 04/2004
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2020 - 10/2006
2	Opioid Analgesics (Opioids)IBA 01/2023 - 09/2010
2	Illicit Drugs (Recreational Drugs)IBA 09/2019 - 09/2010
2	Transaminases (Aminotransferases)IBA 01/2018 - 11/2004
2	faldaprevirIBA 05/2016 - 06/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 06/2015 - 11/2004
2	Biomarkers (Surrogate Marker)IBA 03/2006 - 07/2005
1	elbasvirIBA 01/2023
1	grazoprevirIBA 01/2023
1	ABO Blood-Group SystemIBA 01/2022
1	AlbuminsIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	SofosbuvirIBA 01/2021
1	Coffee FDA Link 01/2019
1	Serum AlbuminIBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Tenofovir (Viread)FDA Link 10/2016
1	Hepatitis B e AntigensIBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 12/2013
1	NucleotidesIBA 12/2013
1	InterleukinsIBA 01/2012
1	Interferon-alpha2bIBA 01/2010
1	Erythropoietin FDA Link 08/2007
1	peginterferon alfa-2b (Pegintron)FDA Link 02/2007
1	Interferon-alpha (Interferon Alfa)IBA 10/2006
1	AcidsIBA 04/2006
1	Hyaluronic Acid (Hyaluronan)IBA 07/2005
1	NucleosidesIBA 11/2004
1	Ferritins (Ferritin)IBA 11/2004
1	EnzymesIBA 04/2004
1	Hepatitis C AntibodiesIBA 04/2004
1	Alanine Transaminase (SGPT)IBA 04/2004
1	Proteins (Proteins, Gene)FDA Link 04/2004
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 04/2004
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2004
1	HaptoglobinsIBA 04/2004
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2004
1	VaccinesIBA 05/2002

Therapy/Procedure

16	Therapeutics 01/2023 - 04/2003
2	Retreatment 01/2018 - 08/2007
2	Duration of Therapy 07/2009 - 11/2004
2	Blood Transfusion (Blood Transfusions) 04/2003 - 01/2002
1	Secondary Prevention 01/2021
1	Transplantation 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 11/2004
1	Body Piercing (Piercing, Body) 05/2004